论文信息 - First-line talazoparib with enzalutamide in HRR-deficient metastatic castration-resistant prostate cancer: the phase 3 TALAPRO-2 trial - 字舞流文

First-line talazoparib with enzalutamide in HRR-deficient metastatic castration-resistant prostate cancer: the phase 3 TALAPRO-2 trial

N. Agarwal | A. Fay | E. Voog | N. Matsubara | J. Joung | S. Zschäbitz | C. Dunshee | C. Healy | Nicola Di Santo | Robert J Jones | Dingwei Ye | A. Azad | Neal D Shore | Joan Carles | Karim Fizazi | Peter C. Fong | U. De Giorgi | Fabian Zohren | Jan Oldenburg | K. Fizazi | Xun Lin | A. D. Laird